Astria Therapeutics

About:

Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.

Website: https://www.astriatx.com/

Twitter/X: AstriaTx

Top Investors: RA Capital Management, Perceptive Advisors, SV Health Investors, Driehaus Capital Management, Adage Capital Management

Description:

Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.

Total Funding Amount:

$656M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)astriatx.com

Founders:

Jill C. Milne, Michael Jirousek

Number of Employees:

11-50

Last Funding Date:

2024-01-30

IPO Status:

Public

© 2025 bioDAO.ai